AstraZeneca

#BreakingNews 📢 Today we announced plans to invest $2 billion to expand our long-standing manufacturing footprint in Maryland. This investment is our fourth major US manufacturing announcement this year and part of the historic $50 billion commitment we made in July. Supporting 2,600 jobs and catalysing economic growth, this investment strengthens the resilience of the US medicines supply chain and accelerates access to transformative therapies for patients across America and around the world. #AZN #WhatScienceCanDo

In order to transform the future of cancer care, collaboration is essential. This week we hosted the inaugural Patient Advocacy Leaders Summit, convening 100 oncology patient advocacy leaders from across the globe. Their collective expertise and passion drove discussions on how to advance access, improve outcomes, and accelerate how we can work together to change the future for patients. Thank you to this inspiring group for your participation, feedback and collaboration.

Cell therapy has the potential to offer long-term remission, or even cure, across multiple diseases. Our approach goes beyond what’s possible today – pushing the boundaries of science by investing in state-of-the-art platforms, expanding global capabilities, and pioneering cell therapies at scale. By doing so, we’re working to eliminate the barriers that stand between patients and potentially life-changing treatments – and bring the future of medicine closer to becoming reality. Learn more here: https://learn.az/60487gh7Y #CellTherapy #Innovation #WhatScienceCanDo

Behind every diagnosis of chronic obstructive pulmonary disease (COPD) is a person with a story, fighting to breathe easier. It is a complex disease, affecting diverse populations with a range of causes. This World COPD Day, we’re encouraging greater COPD understanding to challenge outdated perceptions, support earlier diagnosis, improve access to care and transform patient outcomes worldwide. Join us and help make COPD a global policy priority: https://learn.az/60437d7Qd #WorldCOPDDay #SpeakUpForCOPD

Clostridioides difficile (C. diff) is a bacterium that can cause recurrent, potentially life-threatening infections, affecting hundreds of thousands of people each year. While November is #CdiffAwarenessMonth, our commitment to finding new ways to prevent and treat C. diff continues every day—so we can help people like Minnie. Hear more about Minnie’s decade-long journey with C. diff and why advancing care is so critical: https://learn.az/604775clz #CdiffInfectionAwareness

We have a bold ambition in oncology – to one day eliminate cancer as a cause of death. Our Oncology R&D strategy supports our ambition to transform outcomes for patients by attacking cancer from multiple angles, treating earlier and smarter, and leading with transformational technologies. Susan Galbraith, Executive Vice President, Oncology Haematology R&D, explains how we’re driving momentum and aiming to shape the future of cancer care: https://learn.az/60447dh62 #Innovation #WhatScienceCanDo

We’re using AI to enhance our R&D and drive bolder scientific advances. Outperforming current techniques, AI models MapDiff for therapeutic protein design and Edge Set Attention for molecular property prediction, developed with The University of Sheffield and the University of Cambridge, bring this progress to life. Learn more: https://learn.az/60497kDOD

Living with diabetes affects more than blood sugar. It touches every aspect of well-being — physical, mental and emotional. Creating workplaces that value understanding and support helps ensure everyone can thrive and achieve their ambitions. Together, we can shape a healthier, more inclusive future. #WorldDiabetesDay #WhatScienceCanDo

Over 90 of our employees and 15 Young Health Programme (YHP) Impact Fellows joined world leaders and changemakers from more than 190 countries at last week's One Young World Summit 2025 in Munich.🌍 Aradhana Sarin, our CFO and Executive Director, delivered a keynote alongside YHP Impact Fellows Winnie Olwal ,PMD Pro. and Jakub Gietka CIMA Cert BA, who each received a $50,000 grant to expand their youth-led solutions. Throughout the week, our delegation engaged in reverse mentorship and action-focused discussions. Now, they’re translating insights into initiatives that accelerate progress toward our health equity ambitions. #OYW25 #YoungHealthProgramme #HealthEquity

At the inaugural ESMO AI Congress, we share how transformational technologies—data and AI, computational pathology and digital health—advance cancer research and care. Harnessing AI across oncology discovery, development and beyond accelerates progress, enabling clearer insights, faster decision-making and more precise outcomes in service of our ambition to eliminate cancer as a cause of death. #ESMOAI25 #HealthAI #DigitalOncology